載入...
Tocilizumab and PMX-DHP have efficacy for severe COVID-19 pneumonia
In coronavirus disease 2019 pneumonia, a cytokine storm resulting from an excessive inflammatory response to the viral infection is thought to play a role in the exacerbation of the pneumonia and its prognosis. Favipiravir and ciclesonide are not effective in the inhibition of the cytokine storm. In...
Na minha lista:
| 發表在: | SAGE Open Med Case Rep |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7970680/ https://ncbi.nlm.nih.gov/pubmed/33796310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X21991063 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|